Searching...Lobbying Arrangements: Pharmacy
New Lobbying Registrations About Pharmacy By Quarter
Former Covered Federal Workers:
Other Lobbyists:
| Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
|---|---|---|---|---|---|
| Details Quicker FDA approval of new drug applications |
Pharmacyclics
Pharmaceutical development and manufacturing |
Wexler & Walker Public Policy Associates | |||
| Details Representation on international trade issues affecting generic pharmaceutical industry. |
Generic Pharmaceutical Association
|
GREENBERG TRAURIG, LLP | |||
| Details Issues related to US Patent and Trademark Office accepting late filings in certain cases of unintentional delay |
The Medicines Company
|
Elmendorf Strategies LLC | |||
| Details Monitor developments on health reform legislation. Monitor development regarding online content and services. |
WebMD Health Corp
|
Hogan Lovells US LLP | |||
| Details Any and all legislation affecting the pharmaceutical industry |
Pharmaceutical Industry Labor-Management Association
Labor-management association for the pharmaceutical industry |
Leary Ventures | |||
| Details Reduction of radition dose when imaging pediatric cases. |
InfiMed
|
Hill Partner, LLC | |||
| Details Reauthorization of the Prescription Drug User Fee Act. |
Express Scripts, Inc.
Pharmacy benefit manager |
HOLLAND & KNIGHT LLP | |||
| Details Patent Reform Legislation |
Pharmaceutical Industry Labor-Management Association
|
Mr. Gerald Baker | |||
| Details Issues related to inclusion of prescription drugs within Essential Health Benefit. |
Sunovion Pharmaceuticals, Inc.
|
PATTON BOGGS LLP | |||
| Details Prescription Drug User Fee Act reauthorization. Diabetes drugs issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act.S... |
Bristol-Myers Squibb
|
PODESTA GROUP, INC. | |||
| Details House and Senate legislation on biologic medicines. |
Teva Pharmaceuticals USA
|
KIRKLAND & ELLIS LLP | |||
| Details FY13 Department of Defense Appropriations Orphan drugs and tax issues PDUFA Patient Protection and Innovative Biologic Medicines Act of 2009 Implementation of health care reform Implementation and... |
Novartis
Pharmaceutical Company |
WINNING STRATEGIES WASHINGTON | |||
| Details Generic drug approval issues before Congress and the Executive Branch |
Sanofi-Aventis US
Pharmaceutical company |
BROWNSTEIN HYATT FARBER SCHRECK, P.C. | |||
| Details General pharmaceutical issues |
Cubist Pharmaceuticals, Inc.
Pharmaceutical company |
Capitol Hill Consulting Group | |||
| Details General Pharmaceutical Issues pertaining to the company. No specific legislation General healthcare issues related to pharmaceutical products. No specific legislation |
DFB Pharmaceuticals, Inc.
|
CAPITOL HILL CONSULTING GROUP | |||
| Details Center for Medicare & Medicaid Services (CMS) proposed rule regarding average manufacturers' price |
Walgreen Company
Drug store chain |
Davis Wright Tremaine LLP | |||
| Details Prescription drug industry issues relating to domestic employment and all other issues affecting the industry's U.S.workforce. |
Pharmaceutical Industry Labor Management Association
A labor-management association representing unions and pharmaceutical companies |
Flynn & Associates, Inc. | |||
| Details Internet pharmacy issues. |
Phoenix Capital Management, LLC
Internet Pharmacy. |
Walker, Martin & Hatch, LLC | |||
| Details Innovation Act--HR 9. A bill to promote transparency in patent ownership and make other improvements in the patent system. Entire bill. |
Pharmaceutical Industry Labor-Management Association
|
MR. MICHAEL L. TINER | |||
| Details Governmental representation regarding science and biotechnology industry related issues. |
BayBio
life science industry trade association |
BARNES & THORNBURG LLP | |||
| Details Discussions regarding H.R.5539, the ORPHAN Cures Act |
Daiichi Sankyo, Inc.
|
in-house lobbying | |||
| Details Acquisition of Caremark by CVS |
Caremark Rx, Inc.
Pharmaceutical Services Company |
BROWNSTEIN HYATT FARBER SCHRECK, P.C. | |||
| Details matters affecting the company's pharmaceutical interests |
Mannatech, Inc.
company selling dietary supplements |
Polsinelli Shalton Flanigan Suelthaus PC | |||
| Details Advocate for cost containment policies related to comparative effectiveness, health information technology, and for policies on broader health care reform initiatives (including but not limited to ... |
California Public Employees Retirement System
|
Jennings Policy Strategies | |||
| Details Final promulgation of sunscreen monograph |
Citizens for Sun Protection
Coalition promoting adaption of comprehensive sunscreen standards |
The Accord Group, Inc. | |||
| Details -Advocate for biopharmaceutical cost-containment policies aimed at creating an abbreviated pathway for access to generic biologic medications |
California Employees Public Retirees System
Administers retirement and health benefits for California public employees |
Jennings Policy Strategies | |||
| Details Medicaid, Medicare |
Coalition For Fair and Accurate Rebates
|
BUCHANAN INGERSOLL & ROONEY PC | |||
| Details -Advocate for the creation of a regulatory pathway for generic biologic medications and policies that promote competition in the pharmaceutical marketplace. |
Coalition for a Competitive Pharmaceutical Marketplace
Health care coalition |
JENNINGS POLICY STRATEGIES, INC. | |||
| Details -Advocate for biopharmaceutical cost-containment policies aimed at creating an abbreviated pathway for access to generic biologic medications |
Momenta Pharmaceuticals, Inc.
Biopharmaceuticals |
Jennings Policy Strategies, Inc. | |||
| Details S. 1041, THE EMPLOYEE FREE CHOICE ACT |
Wal-Mart Stores, Inc
Retail Store |
The H2 Group, LLC |